These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2449306)

  • 1. Serum levels of interferons in patients with systemic lupus erythematosus.
    Kim T; Kanayama Y; Negoro N; Okamura M; Takeda T; Inoue T
    Clin Exp Immunol; 1987 Dec; 70(3):562-9. PubMed ID: 2449306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.
    Oke V; Gunnarsson I; Dorschner J; Eketjäll S; Zickert A; Niewold TB; Svenungsson E
    Arthritis Res Ther; 2019 Apr; 21(1):107. PubMed ID: 31036046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus.
    Jin O; Sun LY; Zhou KX; Zhang XS; Feng XB; Mok MY; Lau CS
    Clin Rheumatol; 2005 Apr; 24(2):107-10. PubMed ID: 15818511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms.
    Robak E; Sysa-Jedrzejowska A; Robak T; Smolewski P
    Clin Rheumatol; 2006 Mar; 25(2):225-33. PubMed ID: 16432661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
    Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
    Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.
    Munroe ME; Lu R; Zhao YD; Fife DA; Robertson JM; Guthridge JM; Niewold TB; Tsokos GC; Keith MP; Harley JB; James JA
    Ann Rheum Dis; 2016 Nov; 75(11):2014-2021. PubMed ID: 27088255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal deposition of alpha interferon in systemic lupus erythematosus.
    Panem S; Ordóñez N; Vilcek J
    Infect Immun; 1983 Oct; 42(1):368-73. PubMed ID: 6413415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine.
    Harris BD; Kuruganti S; Deshpande A; Goepfert PA; Chatham WW; Walter MR
    Lupus; 2020 Aug; 29(9):1095-1105. PubMed ID: 32611267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes.
    Struyf NJ; Snoeck HW; Bridts CH; De Clerck LS; Stevens WJ
    Ann Rheum Dis; 1990 Sep; 49(9):690-3. PubMed ID: 1700674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between circulating interferon and anti-interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus.
    Sibbitt WL; Gibbs DL; Kenny C; Bankhurst AD; Searles RP; Ley KD
    Arthritis Rheum; 1985 Jun; 28(6):624-9. PubMed ID: 2408630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variety of endosomal TLRs and Interferons (IFN-α, IFN-β, IFN-γ) expression profiles in patients with SLE, SSc and MCTD.
    Paradowska-Gorycka A; Wajda A; Stypinska B; Walczuk E; Rzeszotarska E; Walczyk M; Haladyj E; Romanowska-Prochnicka K; Felis-Giemza A; Lewandowska A; Olesińska M
    Clin Exp Immunol; 2021 Apr; 204(1):49-63. PubMed ID: 33336388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peripheral blood mRNA and interferon gene expression in systemic lupus erythematosus].
    Tang JP; Gu YY; Shen N; Qian J; Chen XX; Huang XF; Huang XY; Liang D; Guo Q; Yang CD; Bao CD; Chen SL
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):106-10. PubMed ID: 15840221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type III Interferons in Systemic Lupus Erythematosus: Association Between Interferon λ3, Disease Activity, and Anti-Ro/SSA Antibodies.
    Amezcua-Guerra LM; Márquez-Velasco R; Chávez-Rueda AK; Castillo-Martínez D; Massó F; Páez A; Colín-Fuentes J; Bojalil R
    J Clin Rheumatol; 2017 Oct; 23(7):368-375. PubMed ID: 28937472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.
    Robak E; Sysa-Jedrzejewska A; Dziankowska B; Torzecka D; Chojnowski K; Robak T
    Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects.
    Arora V; Verma J; Marwah V; Kumar A; Anand D; Das N
    Lupus; 2012 May; 21(6):596-603. PubMed ID: 22300832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus.
    Rana A; Minz RW; Aggarwal R; Anand S; Pasricha N; Singh S
    Lupus; 2012 Sep; 21(10):1105-12. PubMed ID: 22759859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I interferon correlates with serological and clinical manifestations of SLE.
    Dall'era MC; Cardarelli PM; Preston BT; Witte A; Davis JC
    Ann Rheum Dis; 2005 Dec; 64(12):1692-7. PubMed ID: 15843451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus.
    Robak E; Smolewski P; Wozniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2004; 15(3):222-30. PubMed ID: 15542447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum interferon levels in patients with systemic lupus erythematosus.
    Ytterberg SR; Schnitzer TJ
    Arthritis Rheum; 1982 Apr; 25(4):401-6. PubMed ID: 6176248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon and natural killer cells in systemic lupus erythematosus.
    Strannegård O; Hermodsson S; Westberg G
    Clin Exp Immunol; 1982 Nov; 50(2):246-52. PubMed ID: 6185256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.